943 related articles for article (PubMed ID: 15059071)
1. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
2. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
3. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of children with malignant disease against varicella.
Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
[TBL] [Abstract][Full Text] [Related]
5. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
6. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
7. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
Chaves Tdo S; Lopes MH; de Souza VA; Dos Santos Sde S; Pereira LM; Reis AD; David-Neto E
Pediatr Transplant; 2005 Apr; 9(2):192-6. PubMed ID: 15787792
[TBL] [Abstract][Full Text] [Related]
10. Varicella vaccination in children with steroid-sensitive nephrotic syndrome.
Alpay H; Yildiz N; Onar A; Temizer H; Ozçay S
Pediatr Nephrol; 2002 Mar; 17(3):181-3. PubMed ID: 11956856
[TBL] [Abstract][Full Text] [Related]
11. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
Gershon AA; Steinberg SP
N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
[TBL] [Abstract][Full Text] [Related]
12. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia.
Kappagoda C; Shaw P; Burgess M; Botham S; Cramer L
J Paediatr Child Health; 1999 Aug; 35(4):341-5. PubMed ID: 10457288
[TBL] [Abstract][Full Text] [Related]
13. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
14. Varicella vaccination in children after bone marrow transplantation.
Sauerbrei A; Prager J; Hengst U; Zintl F; Wutzler P
Bone Marrow Transplant; 1997 Sep; 20(5):381-3. PubMed ID: 9339753
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
16. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
19. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
20. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
Chiba Y; Miura J; Kumagai T; Nakao T
Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]